Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis

Joint Bone Spine

Volumn 75, Issue 5, 2008, Pages 597-599

  Hassikou, Hasna ^a   El Haouri, Mohamed ^a   Tabache, Fatima ^a   Baaj, Mohamed ^a   Safi, Somaya ^a   Hadri, Larbi ^a  

^a Military Hospital Moulay Ismail   (Morocco)

Author keywords

Adverse effects; Drug eruptions; Epidermal necrolysis; Leflunomide; Lyell's syndrome; Toxic

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOGLYCOSIDE; ASPARTATE AMINOTRANSFERASE; COLESTYRAMINE; D DIMER; DICLOFENAC; FRESH FROZEN PLASMA; GLYCOPEPTIDE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; QUINOLONE; SALAZOSULFAPYRIDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLISTER; BLOOD CLOTTING; BLOOD CULTURE; BRONCHITIS; CASE REPORT; CATARRHAL CONJUCTIVITIS; CATARRHAL CONJUNCTIVITIS; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FIBEROPTIC BRONCHOSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GINGIVA DISEASE; GINGIVORRHAGIA; HUMAN; HUMAN TISSUE; HYPERTENSION; LEUKOPENIA; LYMPHOCYTIC INFILTRATION; MACULOPAPULAR RASH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUTH ULCER; MUCOUS MEMBRANE EROSION; NAUSEA; PROTHROMBIN TIME; PUNCTATE KERATITIS; RHEUMATOID ARTHRITIS; SEPSIS; SIDE EFFECT; SKIN ALLERGY; SKIN BIOPSY; SKIN DEFECT; SKIN NECROSIS; SKIN ULCER; SYMBLEPHARON; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TONGUE DISEASE; TONGUE EROSION; TOXIC EPIDERMAL NECROLYSIS; TREATMENT RESPONSE; VISUAL IMPAIRMENT;

ADJUVANTS, IMMUNOLOGIC; ADULT; ARTHRITIS, RHEUMATOID; CHOLESTYRAMINE; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GLUCOCORTICOIDS; HUMANS; ION EXCHANGE RESINS; ISOXAZOLES; PREDNISOLONE;

EID: 53149105870     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.08.013     Document Type: Article

References (10)

1. Mohty R., Chaby G., Pannier M., et al. Syndrome d'hypersensibilité médicamenteuse au léflunomide. Ann Dermatol Venereol 130 (2003) 551-552
2. Smolen J.S., Kalden J.R., Scott D.L., et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 353 (1999) 259-266
3. Canonne-Courivaud D., Carpentier O., and Dejobert Y. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 130 (2003) 435-437
4. Holm E.A., Balslev E., and Jemec G.B. Vasculitis occurring during leflunomide therapy. Dermatology 203 (2001) 258-259
5. Fischer T.W., Bauer H.I., Graefe T., et al. Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide. Dermatology 207 (2003) 386-389
6. Kerr O.A., Murray C.S., and Tidman M.J. Subacute cutaneous lupus erythematosus associated with leflunomide. Clin Exp Dermatol 29 (2004) 319-320
7. Teraki Y., Hitomi K., Sato Y., et al. Leflunomide-induced toxic epidermal necrolysis. Int J Dermatol 45 (2006) 1370-1371
8. Roujeau J.C., and Stern R. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 (1994) 1272-1285
9. Begaud B., Evreux J.C., Jouglard J., et al. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 40 (1985) 111-118
10. Wetterwald E., Chosidow O., Bachot N., et al. Syndrome de Lyell (nécrolyse épidermique toxique). Encycl Méd Chir. Dermatologie (2001), Editions Scientifiques et Médicales Elsevier SAS, Paris 13 98-270-A-10